Trial
NCT04044690
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 in Adults With Dermatomyositis (DM)
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
CSL Behring
Collaborators
—
Condition
Dermatomyositis
Intervention
human immunoglobulin G
Why stopped
Primary endpoint not attained
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-09